{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:46Z","timestamp":1761519106358},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1991,6]]},"DOI":"10.1007\/bf03346838","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T13:16:22Z","timestamp":1395926182000},"page":"451-455","source":"Crossref","is-referenced-by-count":29,"title":["Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH"],"prefix":"10.1007","volume":"14","author":[{"given":"Arne Nyholm","family":"Gam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. F.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hasselstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Siersb\u00e6k","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346838_CR1","first-page":"897","volume":"148","author":"B Kirkegaard","year":"1986","unstructured":"Kirkegaard B., Beck K., Bregeng\u00e5rd C., Faber J., Feldt-Rasmussen U. Thyroid stimulating hormone (TSH) in the serum as the first investigation in thyrotoxicosis. Dan. Med. Bull. 148: 897, 1986.","journal-title":"Dan. Med. Bull."},{"key":"BF03346838_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1987.tb00833.x","volume":"27","author":"T Mori","year":"1987","unstructured":"Mori T., Imura H., Bito S., Ikekubo K., Inoue S., Hashida S., Ishikawa E., Ogawa H. Clinical usefulness of highly sensitive enzyme-immuno-assay of TSH. Clin. Endocrinol. (Oxf.) 27: 1, 1987.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03346838_CR3","first-page":"981","volume":"1","author":"S Fraser","year":"1977","unstructured":"Fraser S., Smith D., Anderson J., Wilson G. Osteoporosis and fractures following thyrotoxicosis. Lancet 1: 981, 1977.","journal-title":"Lancet"},{"key":"BF03346838_CR4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1530\/acta.0.0850515","volume":"85","author":"L Mosekilde","year":"1977","unstructured":"Mosekilde L., Meisen F., Bagger J.P., Myhre-Jensen O., Sorensen N.S. Bone changes in hyperthyroidism: Interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol. (Copenh.) 85: 515, 1977.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03346838_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0300-595X(73)80047-7","volume":"2","author":"D Smith","year":"1973","unstructured":"Smith D., Fraser S., Wilson G. Hyperthyroidism and calcium metabolism. Clin. Endocrinol. Metab. 2: 333, 1973.","journal-title":"Clin. Endocrinol. Metab."},{"key":"BF03346838_CR6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/acta.0.0910437","volume":"91","author":"J Linde","year":"1978","unstructured":"Linde J., Friis T. Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinol. (Copenh.) 91: 437, 1978.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03346838_CR7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1210\/jcem-62-5-1056","volume":"62","author":"B Lukert","year":"1986","unstructured":"Lukert B., Higgens J., Stoskopf M. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J. Clin. Endocrinol. Metab. 62: 1056, 1986.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346838_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2007-1012275","volume":"18","author":"M Martinez","year":"1986","unstructured":"Martinez M., Herranz L., de Pedro C., Pallardo L. Osteocalcin levels in patients with hyper- and hypothyroidism. Horm. Metab. Res. 18: 12, 1986.","journal-title":"Horm. Metab. Res."},{"key":"BF03346838_CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jcem-70-1-49","volume":"70","author":"J Faber","year":"1990","unstructured":"Faber J., Perrild H., Johansen J. Bone Gla Protein and Sex Hormone-Binding Globulin in nontoxic goiter: Parameters for metabolic status at the tissue level. J. Clin. Endocrinol. Metab. 70: 49, 1990.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346838_CR10","first-page":"172","volume":"17","author":"K Wenzel","year":"1988","unstructured":"Wenzel K. Does suppressive therapy with levothyroxine (LT4) induce tissue thyrotoxicosis. Ann. Endocrinol. 17: 172, 1988.","journal-title":"Ann. Endocrinol."},{"key":"BF03346838_CR11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0002-9343(87)90219-1","volume":"82","author":"D Ross","year":"1987","unstructured":"Ross D., Neer R., Ridgway E., Daniels G. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am. J. Med. 82: 1167, 1987.","journal-title":"Am. J. Med."},{"key":"BF03346838_CR12","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1001\/jama.1988.03720210027023","volume":"259","author":"T Paul","year":"1988","unstructured":"Paul T., Kerrigan J., Kelly A., Braverman L., Baran D. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 259: 3137, 1988.","journal-title":"JAMA"},{"key":"BF03346838_CR13","unstructured":"Adlin E., Maurer A., Marks A., Channick B. Bone mineral density in postmenopausal women treated with thyroxine. 63rd Annual Meeting of the American Thyroid Association. Montreal Canada, 1988, T\u201317."},{"key":"BF03346838_CR14","unstructured":"Ahmann A., Solomon B., Duncan W., Wartofsky L. Normal Bone Mineral density (BMD) in premenopausal women on suppressive doses of l-thyroxine. 62rd Annual Meeting of the American Thyroid Association. Washington D.C. 1987, T\u201321."},{"key":"BF03346838_CR15","first-page":"122","volume":"18","author":"R Harvey","year":"1989","unstructured":"Harvey R., McHardy K., Robins S., Taylor S., Reid I., Bewsher P. Bone collagen degradation in thyrotoxicosis and thyroxine replacement therapy measured by urinary pyridinoline and deoxypyridinoline excretion. Ann. Endocrinol. 18: 122, 1989.","journal-title":"Ann. Endocrinol."},{"key":"BF03346838_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2265.1989.tb01237.x","volume":"31","author":"E Nystr\u00f6m","year":"1989","unstructured":"Nystr\u00f6m E., Lundberg P., Petersen K., Bentsson C., Lindtstedt G. Evidence for slow tissue adaptation to circulating thyroxine with chronic L-thyroxine treatment. Clin. Endocrinol. (Oxf.) 31: 143, 1989.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03346838_CR17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/00365518009091978","volume":"40","author":"B Kr\u00f6lner","year":"1980","unstructured":"Kr\u00f6lner B., Nielsen S.P. Measurement of bone mineral content (BMC) of the lumbar spine I. Theory and application of a new two-dimensional dual-photon attenuation. Scand. J. Clin. Lab. Invest. 40: 653, 1980.","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"BF03346838_CR18","first-page":"197","volume-title":"Noninvasive bone measurement: Methodological problems","author":"H Bohr","year":"1982","unstructured":"Bohr H., Schaadt O. Influence of age on bone mineral content in the femoral neck measured by dual photon absorptiometry. In: Dequeker J, Johnston C.C. (Eds.), Noninvasive bone measurement: Methodological problems. IRL Press, Oxford, 1982, p. 197."},{"key":"BF03346838_CR19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00365518809085780","volume":"48","author":"L Hyldstrup","year":"1988","unstructured":"Hyldstrup L., Clemmensen I., Jensen B., Transb\u00f8l I. Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic disorders and thyroid disease. Scand. J. Clin. Lab. Invest. 48: 611, 1988.","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"BF03346838_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2265.1990.tb00477.x","volume":"33","author":"C Ribot","year":"1990","unstructured":"Ribot C., Tremollieres F., Pouilles M., Louvet J.P. Bone mineral density and thyroid hormone therapy. Clin. Endocrinol. (Oxf.) 33: 143, 1990.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03346838_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2265.1983.tb02873.x","volume":"8","author":"B Kr\u00f6lner","year":"1983","unstructured":"Kr\u00f6lner B., J\u00f8rgensen J., Nielsen S.P. Spinal bone mineral content in myxedema and thyrotoxicosis. Effect of thyroid hormone and antithyroid treatment. Clin. Endocrinol. (Oxf.) 8: 439, 1983.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03346838_CR22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2265.1989.tb01421.x","volume":"30","author":"S Gow","year":"1989","unstructured":"Gow S., Caldwell G., Toft A., Bechett G. Different hepatic responses to thyroxine replace ment in spontaneous and 131I-induced primary hypothyroidism. Clin. Endocrinol. (Oxf.) 30: 505, 1989.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03346838_CR23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1210\/jcem-66-4-740","volume":"66","author":"D Sarne","year":"1988","unstructured":"Sarne D., Refetoff S., Rosenfield R., Farriaux J. Sex hormone-binding-globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: The value of changes after short term triiodothyronine administration. J. Clin. Endocrinol. Metab. 66: 740, 1988.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346838.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346838\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T20:13:35Z","timestamp":1565295215000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["BF03346838"],"URL":"https:\/\/doi.org\/10.1007\/bf03346838","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}